Eli Lilly and Company (NYSE: LLY) has announced its participation in the upcoming TD Cowen 45th Annual Health Care Conference, scheduled for March 4, 2025. Jake Van Naarden, executive vice president and president of Lilly Oncology, will engage in a fireside chat at 1:50 p.m. Eastern Time.
The event will be streamed live via an audio webcast, accessible on Lilly’s investor website under the “Webcasts & Presentations” section at Lilly Webcasts. A replay of the discussion will be available for approximately 90 days following the event.
About Eli Lilly and Company
Eli Lilly is a global leader in medicine, committed to transforming science into healing and improving lives worldwide. With nearly 150 years of pioneering innovations, the company’s treatments impact tens of millions across the globe. Through breakthroughs in biotechnology, chemistry, and genetic medicine, Lilly is addressing some of the most pressing health challenges, including advancements in diabetes care, obesity treatment, Alzheimer’s disease research, immune system disorders, and innovative cancer therapies.
Lilly is also focused on enhancing clinical trial diversity and ensuring the accessibility and affordability of its medicines. For more information about Eli Lilly, visit Lilly.com and Lilly News, or follow the company on Facebook, Instagram, and LinkedIn.
Trademarks and Trade Names
All trademarks or trade names mentioned in this release are the property of their respective owners. For convenience, trademarks and trade names are referenced without the ® and ™ symbols, though all rights are protected under applicable law. References to third-party trademarks do not imply any endorsement or relationship with the companies.
Related topics
